AU2001276462A1 - Use of natural products in cancer treatment - Google Patents

Use of natural products in cancer treatment

Info

Publication number
AU2001276462A1
AU2001276462A1 AU2001276462A AU7646201A AU2001276462A1 AU 2001276462 A1 AU2001276462 A1 AU 2001276462A1 AU 2001276462 A AU2001276462 A AU 2001276462A AU 7646201 A AU7646201 A AU 7646201A AU 2001276462 A1 AU2001276462 A1 AU 2001276462A1
Authority
AU
Australia
Prior art keywords
cancer treatment
natural products
natural
products
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001276462A
Inventor
Paul Rodney Clayton
David Dexter
Harcharan Rooperai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FORUM BIOSCIENCE
Original Assignee
FORUM BIOSCIENCE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0017620A external-priority patent/GB0017620D0/en
Priority claimed from GB0023574A external-priority patent/GB0023574D0/en
Priority claimed from GB0026600A external-priority patent/GB0026600D0/en
Application filed by FORUM BIOSCIENCE filed Critical FORUM BIOSCIENCE
Publication of AU2001276462A1 publication Critical patent/AU2001276462A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
AU2001276462A 2000-07-18 2001-07-18 Use of natural products in cancer treatment Abandoned AU2001276462A1 (en)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
GB0017620.6 2000-07-18
GB0017620A GB0017620D0 (en) 2000-07-18 2000-07-18 Flavonoids in cancer treatment
GB0017620 2000-07-18
GB0023574.7 2000-09-26
GB0023574A GB0023574D0 (en) 2000-09-26 2000-09-26 Use of natural products in cancer treatment
GB0023574 2000-09-26
GB0026600.7 2000-10-31
GB0026600A GB0026600D0 (en) 2000-10-31 2000-10-31 Use of natural products in cancer treatment
GB0026600 2000-10-31
PCT/GB2001/003150 WO2002005827A2 (en) 2000-07-18 2001-07-18 Use of natural products in cancer treatment

Publications (1)

Publication Number Publication Date
AU2001276462A1 true AU2001276462A1 (en) 2002-01-30

Family

ID=27255810

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001276462A Abandoned AU2001276462A1 (en) 2000-07-18 2001-07-18 Use of natural products in cancer treatment

Country Status (2)

Country Link
AU (1) AU2001276462A1 (en)
WO (1) WO2002005827A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003068202A1 (en) * 2002-02-15 2003-08-21 Dsm Ip Assets B.V. Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
FR2836046B1 (en) * 2002-02-15 2006-09-15 Marie Jose Touche NOVEL THERAPEUTIC APPLICATION OF COMPOUND A: BUTOFORM OR SCUROFORM ASSOCIATED WITH PRODUCT B: EUGENOL AND PRODUCT C: ZINC OXIDE, ADDED TO LYCOPENE
DE10310196A1 (en) * 2003-03-06 2004-09-23 Rina-Netzwerk Rna Technologien Gmbh Use a tricyclic antidepressant to promote endocytosis
US9597311B2 (en) * 2005-09-27 2017-03-21 Robert Benson Aylor Suppression and prevention of tumors
EP2260856A1 (en) 2009-05-12 2010-12-15 URSAPHARM Arzneimittel GmbH Immune stimulating composition comprising an extract of aronia sp. in combination with selenium and/or zinc
US9572783B1 (en) 2015-10-08 2017-02-21 Chuen Wei Lu Use of xanthophylls for the treatment of cancers
EP3153160B1 (en) * 2015-10-08 2021-08-11 Chuen Wei Lu Use of xanthophylls for the treatment of cancers

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4111208A1 (en) * 1991-04-06 1992-10-08 Inge Witte Plant extract for treating cancer - comprises Thuja soln., elder, beetroot, wheat germ oil, lacto- and soya protein and wild yeast
IT1265092B1 (en) * 1993-05-31 1996-10-30 Giuliani Spa PREPARATION FOR USE AS A FOOD OR DIETARY SUPPLEMENT WITH TARGETED RELEASE IN THE COLON
WO1995021542A1 (en) * 1994-02-08 1995-08-17 Vioryl Chemical And Agricultural Industry, Research S.A. A natural and healthy juice
TW542721B (en) * 1997-08-06 2003-07-21 Melaleuca Inc Dietary supplements containing natural ingredients
US6103756A (en) * 1999-08-11 2000-08-15 Vitacost Inc. Ocular orally ingested composition for prevention and treatment of individuals
US6582721B1 (en) * 1999-09-17 2003-06-24 Alcon, Inc. Stable carotene-xanthophyll beadlet compositions and methods of use
WO2001085183A2 (en) * 2000-05-08 2001-11-15 N.V. Nutricia Preparation for the prevention and treatment of ocular disorders

Also Published As

Publication number Publication date
WO2002005827A3 (en) 2002-07-18
WO2002005827A2 (en) 2002-01-24

Similar Documents

Publication Publication Date Title
AU2001288432A1 (en) Materials and methods to potentiate cancer treatment
PL370029A1 (en) 2-amino-4-heteroarylaminopyrimidine derivatives for use in the treatment of cancer
AU6147401A (en) Compositions and methods for the treatment of cancer
AU2001259758A1 (en) Interleukin-1 inhibitors in the treatment of diseases
AU2000260550A1 (en) Treatment of skin damage using polyenylphosphatidylcholine
AU2003284242A1 (en) Methods and compositions for use in treating cancer
HK1162948A1 (en) Hemiasterlin derivatives and uses thereof in the treatment of cancer (hemiasterlin)
AU2001249626A1 (en) Cathepsin inhibitors in cancer treatment
AU2001233739A1 (en) Use of natural substances in the production of cosmetic preparations
AU4340700A (en) Methods and compositions for use in the treatment of hyperlipidemia
PL352330A1 (en) Derivatives of pyridopyranoazepine, making of same and use of same in therapy
AU2001283285A1 (en) Antimicrobial composition and methods of use in the treatment of disease
AU2001282856A1 (en) Human tumor necrosis factor delta and epsilon
AU2001276462A1 (en) Use of natural products in cancer treatment
AU2001261375A1 (en) Human caspase-12 materials and methods
AU2002352566A1 (en) Use of corrinoids in the treatment of skin diseases
AU2002215111A1 (en) Ruthenium-aryl-compounds in cancer therapy
AU2002211690A1 (en) Altered hox and wnt7a expression in human lung cancer
AU2001257325A1 (en) Cancer treatment
AU2001287269A1 (en) Human genes and expression products
AU2002217064A1 (en) Novel use of phospholipids in hair treatment products
AU2003219664A1 (en) Methods and therapeutic compositions in the treatment of advanced cancer
AU2001247214A1 (en) Hair treatment compositions and their use
GB0023574D0 (en) Use of natural products in cancer treatment
GB0026600D0 (en) Use of natural products in cancer treatment